story of the week
Are Clinicians Overdosing Anti-CD20 Agents in Patients With MS?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Neurol Neuroimmunol Neuroinflamm 2023 Sep 01;[EPub Ahead of Print], R Claverie, M Perriguey, A Rico, C Boutiere, S Demortiere, P Durozard, F Hilezian, C Dubrou, F Vely, J Pelletier, B Audoin, A MaaroufFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.